High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.
Plos One
Anfossi, Simone S; Giordano, Antonio A; Gao, Hui H; Cohen, Evan N EN; Tin, Sanda S; Wu, Qiong Q; Garza, Raul J RJ; Debeb, Bisrat G BG; Alvarez, Ricardo H RH; Valero, Vicente V; Hortobagyi, Gabriel N GN; Calin, George A GA; Ueno, Naoto T NT; Woodward, Wendy A WA; Reuben, James M JM